Fuente: Labiotech Lugar: Podcast Today we’re joined by Sean MacDonald, CEO of Kainova Therapeutics and we will dive into Kainova’s innovative GPCR-modulating platform.
The post Reversing tumor immunosuppression with next-gen GPCR modulation appeared first on Labiotech.eu.
© Labiotech UG and Labiotech.eu. Unauthorized use and/or duplication of this material without express and written permission from this site’s author and/or owner is strictly prohibited. Excerpts and links may be used, provided that full and clear credit is given to Labiotech UG and Labiotech.eu with appropriate and specific direction to the original content.